A new, vasoactive hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety

Kitti Szőke, Attila Czompa, István Lekli, Péter Szabados-Fürjesi, Mihály Herczeg, Magdolna Csávás, Anikó Borbás, Pál Herczegh, Árpád Tósaki

Research output: Contribution to journalArticle

3 Citations (Scopus)


Ischemic heart conditions are among the main causes of sudden cardiac death worldwide. One of the strategies for avoiding myocardial infarction is the low-dose, prophylactic use of acetylsalicylic acid (ASA), an inhibitor of platelet aggregation. To avoid the gastrointestinal damage, ASA prodrugs bearing nitric oxide (NO)-donating moiety covalently conjugated to ASA have been synthesized and evaluated extensively worldwide. Herein the synthesis of a new hybrid ASA ester covalently attached to the NO donor linsidomine, an active metabolite of molsidomine (MOL) is reported. Cell viability assay and hemolysis tests were performed in H9c2 cells and rat erythrocytes, respectively. Our new compound, the ERJ-500 not affected negatively the viability of living cells in the concentration range of 100 nM to 100 μM. Using the ex vivo Langendorff method on hearts originated from female rats, compound ERJ-500 displayed a dose-dependent, outwashable vasodilative effect in coronary arteries. Vasodilation was observed on isolated working heart model as well, with elevated stroke volume in hearts treated with ERJ-500. Furthermore, a decreased infarct size was also noticed in ERJ-500 treated hearts after ischemia/reperfusion. Based on these observations it can be expected that our new hybrid ASA may contribute to new pharmacological tool in the therapy of ischemic heart conditions and associated syndromes.

Original languageEnglish
Pages (from-to)159-166
Number of pages8
JournalEuropean Journal of Pharmaceutical Sciences
Publication statusPublished - Apr 1 2019


  • Acetylsalicylic acid
  • Coronary flow
  • Isolated heart
  • Molsidomine
  • Nitrogen oxide liberation
  • Vasoactivity

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'A new, vasoactive hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety'. Together they form a unique fingerprint.

  • Cite this